These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30122371)

  • 21. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
    He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redox homeostasis protects mitochondria through accelerating ROS conversion to enhance hypoxia resistance in cancer cells.
    Li P; Zhang D; Shen L; Dong K; Wu M; Ou Z; Shi D
    Sci Rep; 2016 Mar; 6():22831. PubMed ID: 26956544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
    Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scaffold targeting drug-resistant colon cancers.
    Otrubova K; McGuire KL; McAlpine SR
    J Med Chem; 2007 May; 50(9):1999-2002. PubMed ID: 17411027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy.
    Yang Y; Karakhanova S; Hartwig W; D'Haese JG; Philippov PP; Werner J; Bazhin AV
    J Cell Physiol; 2016 Dec; 231(12):2570-81. PubMed ID: 26895995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
    Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
    Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis.
    Shin SW; Jung W; Choi C; Kim SY; Son A; Kim H; Lee N; Park HC
    Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30558324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
    Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors.
    Park HK; Jeong H; Ko E; Lee G; Lee JE; Lee SK; Lee AJ; Im JY; Hu S; Kim SH; Lee JH; Lee C; Kang S; Kang BH
    J Med Chem; 2017 Sep; 60(17):7569-7578. PubMed ID: 28816449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural Hypoxia is Not a Limiting Factor in Evaluating the Novel Arylidene Derivative MLT-401 Against an In Vitro Colorectal Cancer Model.
    Bin-Jaliah I
    Cell Physiol Biochem; 2018; 46(5):2082-2089. PubMed ID: 29723868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer.
    Xiao K; Li YP; Wang C; Ahmad S; Vu M; Kuma K; Cheng YQ; Lam KS
    Biomaterials; 2015 Oct; 67():183-93. PubMed ID: 26218744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative Stress and Reprogramming of Mitochondrial Function and Dynamics as Targets to Modulate Cancer Cell Behavior and Chemoresistance.
    Falone S; Lisanti MP; Domenicotti C
    Oxid Med Cell Longev; 2019; 2019():4647807. PubMed ID: 31915507
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage.
    Kim H; Lee GR; Kim J; Baek JY; Jo YJ; Hong SE; Kim SH; Lee J; Lee HI; Park SK; Kim HM; Lee HJ; Chang TS; Rhee SG; Lee JS; Jeong W
    Free Radic Biol Med; 2016 Feb; 91():264-74. PubMed ID: 26721593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cordycepin Affects Multiple Apoptotic Pathways to Mediate Hepatocellular Carcinoma Cell Death.
    Zhou Y; Guo Z; Meng Q; Lu J; Wang N; Liu H; Liang Q; Quan Y; Wang D; Xie J
    Anticancer Agents Med Chem; 2017; 17(1):143-149. PubMed ID: 27225448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
    Laws K; Eskandari A; Lu C; Suntharalingam K
    Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LW6, a hypoxia-inducible factor 1 inhibitor, selectively induces apoptosis in hypoxic cells through depolarization of mitochondria in A549 human lung cancer cells.
    Sato M; Hirose K; Kashiwakura I; Aoki M; Kawaguchi H; Hatayama Y; Akimoto H; Narita Y; Takai Y
    Mol Med Rep; 2015 Sep; 12(3):3462-3468. PubMed ID: 26017562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells.
    Zhang X; Kang Y; Huo T; Tao R; Wang X; Li Z; Guo Q; Zhao L
    Free Radic Biol Med; 2017 Nov; 112():49-59. PubMed ID: 28697922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic β-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.
    Wang YY; Chen YK; Hsu YL; Chiu WC; Tsai CH; Hu SC; Hsieh PW; Yuan SF
    Head Neck; 2017 Jun; 39(6):1055-1064. PubMed ID: 28346709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells.
    Ko CH; Shen SC; Yang LY; Lin CW; Chen YC
    Int J Cancer; 2007 Oct; 121(8):1670-9. PubMed ID: 17597109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.